An orally bioavailable small molecule drug candidate targeting colorectal cancer cells with mutated APC gene by inhibiting emopamil binding protein (EBP) to induce cancer cell death.

A series of small molecule inhibitors targeting emopamil binding protein (EBP) to promote remyelination in demyelinating diseases such as multiple sclerosis.